HHS Winds Down $500M in mRNA Vaccine Projects to Support Broader Platforms

Data showing mRNA vaccines underperform against respiratory infections prompted HHS to redirect $500 million toward whole-virus vaccine strategies, novel platforms, expanded non-mRNA research